Sun Pharmaceutical Industries Limited (Sun Pharma) shares closed Oct. 21 at ₹1,745.10 on the National Stock Exchange of India (NSE), recovering from an intraday decline ahead of the company’s Oct. 30 results announcement.
The Economic Times’ live tracker had reported the shares at ₹1,736.60, down 0.37%, at 12:48 a.m. ET (04:48 UTC). By the end of the session, the stock was ₹8.50 above that reported level.
Sun Pharma opened at ₹1,753.00 and traded between ₹1,721.10 and ₹1,755.60. Stock Analysis’ historical price table, which identifies S&P Global Market Intelligence as its data provider, listed volume at 2,316,342 shares.
The Oct. 30 release will cover the quarter and half year ended Sept. 30, according to Sun Pharma’s board-meeting filing. The company has scheduled an earnings call for 9 a.m. ET (13:00 UTC) that day.
